Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- Check2 days agoChange DetectedRemoved 'Schizophrenia' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.1%

- Check9 days agoChange DetectedSchizophrenia is added as a study condition. A Related Topics entry for MedlinePlus Genetics was added.SummaryDifference0.1%

- Check16 days agoChange DetectedThe 'Schizophrenia' topic and the related topic 'MedlinePlus Genetics' have been removed from the page's related topics/MeSH section. This update affects metadata rather than the core study details.SummaryDifference0.1%

- Check23 days agoChange DetectedPublications section wording now clarifies auto-population from PubMed; revision notes updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved the government funding status notice; the primary study details and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedAdded related topics 'Schizophrenia' and 'MedlinePlus Genetics' to the page. These metadata changes do not affect the study details or participation information.SummaryDifference0.1%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.